Company news

Oncolytics Biotech Inc. news in 2025

Oncolytics Biotech Inc.'s news releases, calls and decks from 2025, newest first.

View company

Oncolytics Biotech® to Host Conference Call to Discuss Fourth Quarter and Full Year Financial Results and Recent Operational Highlights

February 25, 2025

Investors Eye Biotech Sector as Cancer Therapy Market Surges

February 19, 2025

Oncolytics Biotech® Advances Key Pancreatic and Anal Cancer Trials, Strengthening Pipeline in 2025

February 19, 2025

Oncolytics Biotech® Advances Key Pancreatic and Anal Cancer Trials, Strengthening Pipeline in 2025

February 19, 2025

Oncolytics Biotech® Strengthens Its Pipeline in 2025 with Key Pancreatic and Anal Cancer Advances in Addition to Metastatic Breast Cancer

February 18, 2025

Oncolytics Biotech® Announces Receipt of Nasdaq Notification Letter Regarding Minimum Bid Price Deficiency

February 13, 2025

Oncolytics Biotech® Announces Matt Coffey, Ph.D. Will Not Return to CEO Role Following Medical Leave of Absence

February 6, 2025

Oncology's Best Minds Set to Meet at Upcoming 2025 ASCO Gastrointestinal Cancers Symposium

January 22, 2025

← Newer news releases

Calls in 2025

Decks in 2025